Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
CONTRAFECT Corp (CFRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/14/2023 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"ContraFect Reports Second Quarter 2023 Financial Results and Provides Business Update"
03/31/2023 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"ContraFect Reports Fourth Quarter 2022 and Full Year 2022 Financial Results and Provides Business Update"
11/14/2022 8-K Quarterly results
08/15/2022 8-K Quarterly results
05/16/2022 8-K Quarterly results
03/24/2022 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"ContraFect Reports Fourth Quarter 2021 and Full Year 2021 Financial Results and Provides Business Update"
11/15/2021 8-K Quarterly results
Docs: "ContraFect Reports Third Quarter 2021 Financial Results and Provides Corporate Update"
08/13/2021 8-K Quarterly results
03/30/2021 8-K Quarterly results
11/13/2020 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : November 13, 2020 ContraFect Corporation Delaware 001-36577 39-2072586 28 Wells Avenue, 3rd Floor, Yonkers, New York 10701 207-2300 Registrant's telephone number, including area code N/A Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commen...",
"ContraFect Reports Third Quarter 2020 Financial Results and Provides Business Update"
08/14/2020 8-K Quarterly results
05/15/2020 8-K Quarterly results
03/18/2020 8-K Quarterly results
Docs: "ContraFect Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update"
11/12/2019 8-K Quarterly results
08/09/2019 8-K Quarterly results
05/10/2019 8-K Quarterly results
Docs: "FORM 8-K",
"ContraFect Reports First Quarter 2019 Financial Results and Provides Business Update"
03/14/2019 8-K Quarterly results
Docs: "FORM 8-K",
"ContraFect Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update"
11/08/2018 8-K Quarterly results
Docs: "ContraFect Announces Third Quarter 2018 Financial Results YONKERS, NY - November 8, 2018 — ContraFect Corporation , a clinical-stage biotechnology company focused on the discovery and development of protein and antibody therapeutics for life-threatening, drug-resistant infectious diseases, today announced results for the third quarter ended September 30, 2018. “We made meaningful steps this past quarter in both the clinical and corporate sides of our business, including completing enrollment in our ongoing Phase 2 clinical trial of exebacase and securing funding that extends our cash runway into the first quarter of 2020,” said Steven C. Gilman, Ph.D., Chairman and Chief Executive Officer of ContraFect. “In addition to these key milestones, our R&D team presented data on our lysins at scie..."
08/09/2018 8-K Quarterly results
Docs: "ContraFect Announces Second Quarter 2018 Financial Results"
05/10/2018 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : May 10, 2018 ContraFect Corporation Delaware 001-36577 39-2072586 28 Wells Avenue, 3rd Floor, Yonkers, New York 10701 207-2300 Registrant's telephone number, including area code N/A Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencemen...",
"ContraFect Announces First Quarter 2018 Financial Results"
03/15/2018 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : March 15, 2018 ContraFect Corporation Delaware 001-36577 39-2072586 28 Wells Avenue, 3rd Floor, Yonkers, New York 10701 207-2300 Registrant's telephone number, including area code N/A Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencem...",
"ContraFect Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update"
11/09/2017 8-K Quarterly results
Docs: "ContraFect Announces Third Quarter 2017 Financial Results"
08/09/2017 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : August 9, 2017 ContraFect Corporation Delaware 001-36577 39-2072586 28 Wells Avenue, 3rd Floor, Yonkers, New York 10701 207-2300 Registrant's telephone number, including area code N/A Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencem...",
"ContraFect Announces Second Quarter 2017 Financial Results"
11/09/2016 8-K Form 8-K - Current report
08/09/2016 8-K Quarterly results
Docs: "ContraFect Announces Second Quarter 2016 Results"
05/10/2016 8-K Quarterly results
Docs: "ContraFect Announces First Quarter 2016 Results"
03/15/2016 8-K Quarterly results
Docs: "ContraFect Announces Fourth Quarter and Full Year 2015 Results"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy